| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |